Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medication refill patterns and mortality in U.S. adults aged 85+: a retrospective Medicare cohort study.

The Gerontologist·2026
Same author

Causal networks guiding large language models: application to COVID-19.

Health care management science·2025
Same author

Artificial Intelligence for Management of Major Depression: Initial Design, Progress, and Research Plans.

Alpha psychiatry·2025
Same author

The United States Preventive Services Task Force (USPSTF) Guidelines vs. Electronic Health Record (EHR)-Based Screening: A Comparative Accuracy Study in Prostate Cancer.

Cureus·2025
Same author

Machine learning driven diabetes care using predictive-prescriptive analytics for personalized medication prescription.

Scientific reports·2025
Same author

Tutorial on Multiple Mediation Analysis Using Causal Networks: Application to Diagnosing COVID-19 From Its Early and Late Symptoms.

Quality management in health care·2025

Related Experiment Video

Updated: Jun 10, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Improved Statistical Methods are Needed to Advance Personalized Medicine.

Farrokh Alemi1, Harold Erdman, Igor Griva

  • 1Department of Health System Administration, School of Nursing and Health Studies, Georgetown University Medical Center, 3700 Reservoir Rd NW, Washington DC 20057, USA.

The Open Translational Medicine Journal
|August 3, 2010
PubMed
Summary

New statistical methods are needed for personalized medicine, moving beyond group-based analysis. The sequential k-nearest neighbor analysis offers a promising approach to tailor treatment efficacy for individual patients.

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Related Experiment Videos

Last Updated: Jun 10, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Area of Science:

  • Biostatistics
  • Personalized Medicine
  • Computational Statistics

Background:

  • Traditional statistical methods like Analysis of Variance (ANOVA) and Discriminant Analysis focus on group differences, potentially overlooking individual patient needs.
  • These methods may provide generalized treatment recommendations that are not optimal for specific patient subgroups, especially with large numbers of subgroups.
  • The advancement of personalized medicine necessitates novel statistical approaches capable of leveraging extensive patient data for tailored therapeutic strategies.

Purpose of the Study:

  • To introduce and evaluate a new statistical method for personalized medicine that addresses the limitations of traditional group-based analyses.
  • To demonstrate how advanced statistical techniques can enable treatment efficacy to be customized for individual patients based on their unique characteristics.
  • To highlight the potential of patient-centric statistical models in improving therapeutic outcomes.

Main Methods:

  • The study introduces the sequential k-nearest neighbor analysis, also termed the patients-like-me algorithm.
  • This method involves sequentially examining the k most similar patients to the patient-at-hand.
  • The process continues until a statistically significant conclusion regarding treatment efficacy for the specific patient is reached.

Main Results:

  • The sequential k-nearest neighbor analysis can provide statistically significant treatment recommendations for individual patients.
  • In certain cases, the algorithm may yield conclusions before processing all available data, offering personalized advice.
  • This personalized advice may diverge from recommendations applicable to the average patient, reflecting individual variability.

Conclusions:

  • The sequential k-nearest neighbor analysis represents a significant advancement in statistical methodology for personalized medicine.
  • This approach has the potential to deliver more effective and individualized treatment recommendations compared to traditional methods.
  • Further development of statistical tools is crucial for realizing the full potential of personalized medicine and improving patient care.